Diabetes Management Resource Center
Home
Formulary Coverage
Tools for Health Care Professionals
Video Presentations
Online Resources
Support and Educational Materials for Patients
Savings Offer
Free 30-Day Supply Voucher
Merck Patient Assistance Program
Patient Education Handouts
Mobile App for Patients With Diabetes
The Science Behind Type 2 Diabetes
Understanding Incretins
Insulin Secretion
Insulin Secretion Abnormalities
DPP-4
Evolution of Incretin Science
Prescribing Information
Medication Guide
Contact Us
References
Home
Formulary Coverage
Tools for Health Care Professionals
Video Presentations
Online Resources
Support and Educational Materials for Patients
Savings Offer
Free 30-Day Supply Voucher
Merck Patient Assistance Program
Patient Education Handouts
Mobile App for Patients With Diabetes
The Science Behind Type 2 Diabetes
Understanding Incretins
Insulin Secretion
Insulin Secretion Abnormalities
DPP-4
Evolution of Incretin Science
Prescribing Information
Medication Guide
Contact Us
References
Important Information About JANUMET and JANUVIA
JANUMET is indicated, as an adjunct to diet and exercise, to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate.
JANUVIA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
JANUMET / JANUVIA should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis.
JANUMET / JANUVIA have not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk of developing pancreatitis while taking JANUMET / JANUVIA.
Please read the Boxed Warning for JANUMET about lactic acidosis.
JANUMET is indicated, as an adjunct to diet and exercise, to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate.
JANUVIA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
JANUMET / JANUVIA should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis.
JANUMET / JANUVIA have not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk of developing pancreatitis while taking JANUMET / JANUVIA.
Please read the Boxed Warning for JANUMET about lactic acidosis.
